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Bone marrow stromal cells are regulated by the chemical and physical
features of a biomaterial surface. When grown on titanium (Ti) and Ti
alloy surfaces, such as titanium-aluminum-vanadium, with specific
topographies that mimic the microscale, mesoscale, and nanoscale
features of an osteoclast resorption pit, they undergo a rapid change in
cell shape to assume a columnar morphology typical of a secretory
osteoblast. These cells exhibit markers associated with an osteoblast
phenotype, including osteocalcin and osteopontin, and they secrete
factors associated with osteogenesis, including bone morphogenetic
protein 2, vascular endothelial growth factor, and neurotrophic
semaphorins. The pathway involves a shift in integrin expression from
a5b1 to a2b1 and signaling by Wnt5a rather than Wnt3a. Conditioned
media from these cultures can stimulate vasculogenesis by human
endothelial cells and osteoblastic differentiation of marrow stromal
cells not grown on the biomimetic substrate, suggesting that the
surface could promote osteogenesis in vivo through similar
mechanisms. In vivo studies using a variety of animal models confirm
that implants with biomimetic surfaces result in improved
osseointegration compared with Ti implants with smooth surfaces, as
do meta-analyses comparing clinical performance of implant surface
topographies.

B

one-facing nonresorbable implant components capable of bone
ingrowth provide implant stability through the formation of a
mechanical interlock. Over two decades, refinements have focused on
pore size, pore configuration, modulus of elasticity at the interface with the
bone, and degree of micromotion during initial bone ingrowth.1 The advent of
spine interbody fusion devices opened the door to examine the possibility
that modifications to the surface at the microscale would improve bone formation and osseointegration of the implant. The dental implant industry
provided a large literature on clinical success of a variety of surface designs,
particularly on titanium implants.2,3 The preclinical information underlying
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Bone must be able to respond to a variety of loading
conditions, requiring it to be metabolically active, continuously remodeling in response to mechanical stimulation, systemic factors such as hormones, and local
factors produced by cells present within the tissue. Bone
tissue consists of a mineralized type I collagen matrix;
osteoblast lineage cells that synthesize, calcify, and
maintain the matrix; osteoclasts that resorb the matrix
and prepare it for subsequent rounds of formation; and
osteocytes, the most abundant bone cell, that coordinate
the activity of osteoblasts and osteoclasts and may also
resorb the bone matrix.7 Bone tissue also contains a
complex vascular network together with its associated
nerves and immune lineage cells, including monocytes,
macrophages, and lymphocytes.8,9
When an implant is placed in the bone, fluid at the
surgical site adsorbs onto the surface. The affinity for and
conformation of proteins on the surface are determined by
its physical and chemical properties. One of the constituents in the wound fluid, fibronectin, adsorbs onto the
surface and provides binding sites for the alpha 5 beta 1
(a5b1) integrins present in MSCs. The clot that forms
between the bone bed and the implant surface also
contains a complex fibrillar network that enables MSCs
to migrate to the site.10 Monocytes and macrophages are
also present at the site, and recent studies indicate that Ti
substrates that have a complex microscale topography
similar to an osteoclast resorption pit and have a
hydrophilic surface chemistry support the prohealing
macrophage M2 phenotype rather than the proinflammatory M1 phenotype.9,11 The MSCs produce factors that modulate the response of immune cells within
the environment, and the immune cells produce factors
that recruit additional MSCs and immune cells.12,13
These surface properties also support osteoblastic
differentiation of MSCs. When grown on such a surface,

MSCs undergo a change in cell polarity, assuming a
columnar morphology rather than being flattened and
spread.14 Their integrin profile changes from predominantly a5b1 to a2b1 and a1b1, which bind RGD and
GFOGR motifs in type 1 collagen.10,15 In addition, they
express markers associated with an osteoblast phenotype, including osteocalcin and osteopontin, and factors
associated with modulation of osteoclast activity such as
osteoprotegerin, which is a decoy receptor for RANK
ligand, and transforming growth factor beta 1.16,17 These
changes occur rapidly and do not require the addition of
any osteogenic media implants, such as dexamethasone
or beta-glycerol phosphate.18 The MSCs also express
factors associated with vasculogenesis, such as vascular
endothelial growth factor-165 and fibroblast growth
factor-2, and factors associated with neurogenesis, such
as semaphorins 3A, 3C, and 4A.13,19
Analysis of Ti, titanium-zirconium, and titaniumaluminum-vanadium (Ti6Al4V) surfaces that have been
generated using various grit blasting/acid etching methods
shows that osteoblastic differentiation of MSCs and osteoprogenitor cells is favored by topographies that mimic
osteoclast resorption pits created during normal bone remodeling5,6 (Figure 1). The osteoclast resorption pit has
an average width of 30 to 100 mm, an average depth of
8 mm, and a nanotextured surface averaging 60 nm.
Moreover, the pits are not isolated on the surface but are
linked to each other by a scalloped border, created as the
osteoclast migrates across the bone surface.20
The most effective biomimetic surfaces have irregular
closely spaced microscale pits overlaid with microscale,
mesoscale, and nanoscale textures that are shaped like

Figure 1

Photograph showing an osteoclast resorbing a bone surface
and leaving the organic matrix exposed. Image courtesy of
Prof Tim Arnett, University College London.
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the clinical studies indicated that surfaces that had a
microstructure resembling an osteoclast resorption pit
supported the more robust osteogenic response based
on a number of outcomes, including osteoblast differentiation of bone marrow stromal cells (MSCs) and osteoprogenitor cells.4 These studies, discussed later, also
examined the mechanisms involved in the osteogenic
response, enabling the application of this literature to
orthopaedic implants manufactured using titanium and
its alloys.5,6
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media on osteoblastic differentiation of MSCs not on
the biomimetic surface. As noted above, growth on an
osteoclast resorption pit biomimetic surface modulates
factors produced by MSCs that regulate inflammation,
vasculogenesis, bone remodeling, and neurogenesis.24,25
This suggests that they might generate an osteoinductive
milieu around the implant surface in vivo.

Effect of Surface Topography on
Osteogenesis In Vivo
Cell culture provides a method for understanding the
mechanisms involved in the response of cells and tissues
to surface topography, but it does not provide definitive
evidence that this affects osseointegration in vitro. Metaanalyses of clinical outcomes using various Ti dental
implant topographies showed a strong correlation
between clinical success and the expression of osteocalcin
by cells grown on identical surfaces in vitro.2,3 To
begin to assess whether the implant surface design could
affect osseointegration in the skeletal bone, we have
conducted a number of studies including the use of gritblasted Ti6Al4V pedicle screws in sheep spine, gritblasted/acid-etched Ti and Ti6Al4V screws in rat and
rabbit femurs, and grit-blasted/acid-etched Ti screws in
osteoporotic rat femoral bone.26-28 Animal models have
also been used to assess the effectiveness of Ti implants
with hydrophilic, microtextured surfaces in diseases, such

Figure 2
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Diagram showing mechanisms involved in the regulation of osteoblastic differentiation of bone marrow stromal cells (MSCs) on
microstructured Ti-based implant surfaces. MSCs migrate to the implant environment and attach by a5b1 integrin binding to
fibronectin. MSCs begin to sense the implant architecture shifting from production of a2b1 integrin binding to collagen type 1 and
upregulate noncanonical Wnt11 (left panel). Wnt11 acts internally and externally of the cell to increase the number of preosteoblasts in
the implant environment. This method is achieved by increasing production Wnt5a and RUNX2 transcription in the nucleus (middle
panel). These preosteoblasts mature into osteoblasts that produce robust concentrations of bone morphogenetic proteins 2 and 4,
osteoprotegerin (OPG), and vascular endothelial growth factor (VEGF) necessary for bone apposition and mineralization (right panel).
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pointed isosceles triangles,5 reminiscent of osteoclasts’
resorption pits with the mesoscale and nanoscale
structures on the resorption pit surface. When MSCs
and osteoprogenitor cells are cultured on these surfaces,
they produce high levels of BMP221 and express receptors for BMP2, indicating that they are inducing the
osteoblast phenotype using autocrine and paracrine
mechanisms.22 This hypothesis is supported by the observation that addition of anti-BMP222 antibodies to the
cultures blocks the effect of the surface on osteoblast differentiation. In addition, they produce Wnt11,23 causing a
shift from producing Wnt3a to Wnt5a (Figure 2).
Recent work has shown that semaphorins are also
involved in mediating the effects of surface topography on
osteoblastic differentiation of MSCs. Semaphorin 3A
(sema3A) can work independently of Wnt3a, Wnt5a, and
BMP2 to enhance osteoblast differentiation, with activation of sema3A occurring alongside of Wnt5A.19 Addition
of antisema3A antibodies to cultures of MSCs grown on
microtextured Ti substrates blocks the effect of the surface on osteoblastic differentiation of MSCs, indicating
the important role that these factors play in the process.
These results also imply that factors produced by
MSCs on the surface could regulate the osteoblast differentiation of MSCs and osteoprogenitor cells not on the
surface, and this is exactly what coculture studies show to
be the case.22 Addition of anti-BMP2 antibodies to MSC
cultures blocks the stimulatory effect of the conditioned
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Most studies examining the role of surface topography in
osteoblast differentiation have used polymeric constructs
on tissue culture polystyrene surfaces to tease out the various contributions of stiffness and shape.15,29 These studies
have relied on the use of osteogenic culture media, which
are high in Ca11 and have additives such as dexamethasone, which simulates alkaline phosphatase activity,
together with a phosphate source such as beta-glycerol
phosphate. Even with these additives, the MSCs or osteoprogenitor cells must form multicellular nodules before
they begin to express an osteoblast phenotype, and
the mineral that they deposit is due, at least in part, to the
high calcium phosphate ion product that is generated by
the action of alkaline phosphatase.18 Numerous studies
have shown that these effects are mediated by Wnt3a
signaling. By contrast, when cells are cultured on osteoclast resorption pit biomimetic Ti surfaces, they shift from
Wnt3a to Wnt5a signaling while still in monolayer.14,19,23
This shift requires a2b1 integrin signaling and is accompanied by a change in cell shape. Certainly, the polymer
models provide valuable insights into MSC regulation, but
without the microscale surface topography to underlie the
nanofeatures, the results must be viewed with caution.
A wide variety of nanomodifications have been
applied to implant surfaces to improve clinical outcomes.
Some of these modifications are applied to machined
surfaces, and their effectiveness in vitro is assessed using
osteogenic media and only limited assessment of outcome measures.30 Even when nanofeatures are generated on microstructured topographies resembling an
osteoclast resorption pit, the specific shapes, sizes, and
crystallinities of the nanostructures result in very different outcomes.5,6,31 Although some of these do support osteoblastic differentiation of MSCs to some
extent, the full panoply of outcomes is observed in
only a limited subset of modifications.31

We have demonstrated that specific nanoscale topographies activate preosteoblastic cell differentiation32
through a mechanism involving integrin-mediated focal
adhesion kinase.33 In addition, these biomimetic nanotopographies enhance bone graft osteointegration.34
More recently, we have demonstrated that hydroxyapatite particle density regulates preosteoblastic cell differentiation.35,36 Importantly, when specific nanofeatures
are applied to microtextured Ti6Al4V surfaces with a
biomimetic osteoclast resorption pit topography, MSCs
and preosteoblasts display the full panoply of characteristics associated with well-differentiated osteoblasts and
produce factors that support osteogenesis, vasculogenesis,
neurogenesis, and prohealing immune response.11,21
Taken together, these studies suggest that specific
nanofeatures, as well as their density and the underlying
substrate topography, may positively affect osteointegration. Investigators have taken advantage of this
observation by applying nanofeatures, such as Ti nanotubes or hydroxyapatite crystals, to the surface of polymeric materials, such as polyether-ether-ketone, to
render them more osteogenic.37-39 However, the
underlying material lacks the microtopography that
recapitulates the biomimetic topography that favors
osteogenesis. Thus, even with bone ingrowth from the
bone bed by creeping substitution, the interface with the
implant is not bone outgrowth but fibrous connective
tissue.40

Summary
Collectively, there is strong preclinical and clinical success supporting the use of implants that possess biomimetic surface topography. Using these surfaces, we have
been able to elucidate the behavior of cells as they sense
and respond to materials. Understanding these mechanisms is key to predict how the next generation of
orthopaedic implants will need to be designed to improve
implant longevity, reduce healing time, and reduce biofilm formation.
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